Table 2.
Lean subjects | Obese subjects | |||||
---|---|---|---|---|---|---|
Pre-exposure | Post-exposure | P value | Pre-exposure | Post-exposure | P value | |
Glucose AUCm (mmol/L * 120 min) | 664 (584–767) | 670 (595–784) | 0.484 | 748 (674–868) | 669 (620–734) | 0.069 |
Insulin AUCm (pmol/L * 120 min) | 29,029 (22,069–38,126) | 24,879 (15,893–38,851) | 0.779 | 55,900 (43,236–96,831) | 36,448 (25,213–57,711) | 0.012 |
HOMA-IRm | 0.36 (0.18–0.68) | 0.59 (0.18–1.1) | 0.161 | 2.46 (1.19–5.77) | 2.10 (0.92–4.25) | 0.263 |
HOMA-IR AUCm | 1181 (797–1449) | 1076 (578–1560) | 0.674 | 2405 (1649–4655) | 1229 (896–2348) | 0.012 |
Glucose AUCe (mmol/L * 120 min) | 742 (695–818) | 641 (504–750) | 0.036 | 735 (614–988) | 644 (568–829) | 0.017 |
Insulin AUCe (pmol/L * 120 min) | 32,836 (18,823–42,053) | 25,698 (24,244–42,143) | 0.575 | 35,446 (23,694–52,771) | 38,390 (25,664–104,861) | 0.208 |
HOMA-Ire | 0.35 (0.20–0.65) | 0.42 (0.18–0.79) | 0.036 | 1.43 (0.29–3.78) | 2.24 (1.20–3.25) | 0.093 |
HOMA-IR AUCe | 1198 (799–1731) | 975 (714–1290) | 0.263 | 1296 (828–2666) | 1356 (931–5359) | 0.401 |
EEm (kcal/day) | 1673 (1441–1893) | 1539 (1431–1925) | 0.889 | 2047 (1890–2214) | 2011 (1814–2305) | 0.327 |
EEe (kcal/day) | 1694 (1542–2009) | 1666 (1473–1784) | 0.208 | 1996 (1940–2304) | 2211 (1887–2356) | 0.575 |
RQm | 0.78 (0.76–0.81) | 0.79 (0.76–0.85) | 0.401 | 0.81 (0.76–0.90) | 0.80 (0.79–0.85) | 0.889 |
RQe | 0.80 (0.79–0.84) | 0.78 (0.75–0.80) | 0.161 | 0.83 (0.80–0.85) | 0.82 (0.79–0.91) | 0.833 |
Weight m (kg) | 71.4 (6301–79.3) | 70.7 (63.3–80.0) | 0.399 | 103.6 (95.9–131.4) | 104.3 (96.6–133.5) | 0.176 |
Weight e (kg) | 70.1 (64.3–80.2) | 70.7 (64.5–80.8) | 0.176 | 104.3 (97.9–133.3) | 105.4 (96.4–134.1) | 0.865 |
Absolute effect of administration of bromocriptine compared with its prior pre-exposure visit. Data presented as n or as median (interquartile ranges). Differences between visits were calculated with the Wilcoxon signed-rank test. HOMA-IR, homeostatic model assessment – insulin resistance, calculated as (glucose (mmol/L) × insulin (U/L))/(22.5). m: outcome after treatment with bromocriptine in the morning. e: outcome after treatment with bromocriptine in the evening. AUC, area under the curve; EE, energy expenditure; RQ, respiratory quotient. Bold indicated statistical significance (P < 0.05).